The companies selling BPC 157 and the media designed to boost its popularity focus on the part stating have demonstrated consistently positive and prompt healing effects for various injury types, but fail to mention the part stating, the majority of studies have been performed on small rodent models and the efficacy of BPC 157 is yet to be confirmed in humans. This means, simply, we have no evidence it works in human tissue
Retatrutide is not approved in Australia
Edge MD, Johnson SL, Ng T, Carver CS
This can undermine motivation, trigger body image concerns, and lead to premature discontinuation of a medication that is otherwise working well
Approved medications have labels, contraindications, known monitoring expectations, and real-world prescribing experience
This syndrome is caused by a FMO3 liver enzyme malfunction, leading to trimethylamine (TMA) accumulation